RICHARD PETERS
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
PATRICIA L. ALLEN, DAVID ARKOWITZ, KEITH A. BAKER, KEITH A. BAKER, M. JAMES BARRETT, RAYMOND BARTOSZEK, MICHAEL CASEY, MEENU CHHABRA, N. ANTHONY COLES, BERNARD DAVITIAN, KIM C. DRAPKIN, KIMBERLEE C. DRAPKIN, SCOTT J. DYLLA, MARION R. FOOTE, MARION R. FOOTE, JEFFREY GOLDBERG, THIERRY GUILLAUDEUX, MARKUS HAEBERLEIN, RICHARD A. HEYMAN, SHAWN IADONATO, SHAWN P. IADONATO, JEFFERY KELLY, JEFFERY W. KELLY, PAULINE KENNY, STEPHEN KNIGHT, STEPHEN KNIGHT, M.D., IRENA MELNIKOVA, CHRISTOPHER MIRABELLI, CHRISTOPHER K. MIRABELLI, PAULASH MOHSEN, WALTER NEWMAN, CRAIG W. PHILIPS, CRAIG W. PHILIPS, CECIL B. PICKETT, PETER H. REINHART, BRIGITTE ROBERTSON, PAULINE JEN RYAN, LAUREN SILVERMAN, LAUREN SILVERMAN, PH.D., HENRY SKINNER, HENRY B. SKINNER, JANET SMART, NADIA USTARIZ, CHRISTOPHER WALSH, CHRISTOPHER T. WALSH, CONOR WALSHE, ALAN WALTS, PH.D., LYNNE ZYDOWSKY
EXECUTIVE OFFICER, DIRECTOR
PATRICIA L. ALLEN, DAVID ARKOWITZ, KEITH A. BAKER, KEITH A. BAKER, M. JAMES BARRETT, RAYMOND BARTOSZEK, MICHAEL CASEY, MEENU CHHABRA, N. ANTHONY COLES, BERNARD DAVITIAN, KIM C. DRAPKIN, KIMBERLEE C. DRAPKIN, SCOTT J. DYLLA, MARION R. FOOTE, MARION R. FOOTE, JEFFREY GOLDBERG, THIERRY GUILLAUDEUX, MARKUS HAEBERLEIN, RICHARD A. HEYMAN, SHAWN IADONATO, SHAWN P. IADONATO, JEFFERY KELLY, JEFFERY W. KELLY, PAULINE KENNY, STEPHEN KNIGHT, STEPHEN KNIGHT, M.D., IRENA MELNIKOVA, CHRISTOPHER MIRABELLI, CHRISTOPHER K. MIRABELLI, PAULASH MOHSEN, WALTER NEWMAN, CRAIG W. PHILIPS, CRAIG W. PHILIPS, CECIL B. PICKETT, PETER H. REINHART, BRIGITTE ROBERTSON, PAULINE JEN RYAN, LAUREN SILVERMAN, LAUREN SILVERMAN, PH.D., HENRY SKINNER, HENRY B. SKINNER, JANET SMART, NADIA USTARIZ, CHRISTOPHER WALSH, CHRISTOPHER T. WALSH, CONOR WALSHE, ALAN WALTS, PH.D., LYNNE ZYDOWSKY
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-12-10
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-12-16
D
OTHER HEALTH CARE
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-12-22

